{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:33:35Z","timestamp":1787114015775,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100028585","name":"American Council of Independent Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100028585","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clinthera.2026.03.019","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T19:54:36Z","timestamp":1776887676000},"page":"867-875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Regional (in)Consistency and Comparability of Cannabis Laboratory Testing: A Statistical Exploration of Total Yeast and Mold"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1956-1182","authenticated-orcid":false,"given":"Graham","family":"Antoszewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9604-0100","authenticated-orcid":false,"given":"Heather","family":"Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2312-5828","authenticated-orcid":false,"given":"Jini","family":"Glaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0932-797X","authenticated-orcid":false,"given":"Mackenzie","family":"Slade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2026.03.019_bib0001","unstructured":"National Conference of State Legislatures. State cannabis legislation database. https:\/\/www.ncsl.org\/health\/state-cannabis-legislation-database (accessed 2025-07-24)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0002","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.foodcont.2012.03.007","article-title":"Methods for fitting the Poisson-lognormal distribution to microbial testing data","volume":"27","author":"Williams","year":"2012","journal-title":"Food Control"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1192035","article-title":"Total yeast and mold levels in high THC-containing cannabis (Cannabis sativa L.) inflorescences are influenced by genotype, environment, and pre-and post-harvest handling practices","volume":"14","author":"Punja","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0004","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijfoodmicro.2004.10.027","article-title":"Microbiological risk assessment models for partitioning and mixing during food handling","volume":"100","author":"Nauta","year":"2005","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0005","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.foodcont.2011.01.029","article-title":"A comparison between the discrete Poisson-gamma and Poisson-lognormal distributions to characterise microbial counts in foods","volume":"22","author":"Gonzales-Barron","year":"2011","journal-title":"Food Control"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0006","unstructured":"Cresco labs exiting California cannabis market. Cannabis Business Times. https:\/\/www.cannabisbusinesstimes.com\/us-states\/california\/news\/15751086\/cresco-labs-exiting-california-cannabis-market (accessed 2025-07-25)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0007","unstructured":"Roberts C. California shutters marijuana testing lab for 7 alleged violations. MJBizDaily. https:\/\/mjbizdaily.com\/california-shutters-marijuana-testing-lab-belcosta-for-alleged-violations\/ (accessed 2025-07-25)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0008","unstructured":"Cannabis regulators order testing lab to suspend operations | WWLP. https:\/\/www.wwlp.com\/news\/massachusetts\/cannabis-regulators-order-testing-lab-to-suspend-operations\/(accessed 2025-07-25)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0009","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/10826076.2021.1996390","article-title":"The analytical landscape of cannabis compliance testing","volume":"44","author":"Goldman","year":"2021","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0010","unstructured":"Roberts C. California revokes marijuana testing lab license over fake results. MJBizDaily. https:\/\/mjbizdaily.com\/news\/california-regulators-revoke-marijuana-testing-lab-license-for-faking-results\/393696\/ (accessed 2026-03-02)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0011","unstructured":"Marijuana product recall \u2013 November 17, 2021. State of Michigan. https:\/\/www.michigan.gov\/cra\/marijuana-product-recall-november-17-2021 (accessed 2026-03-02)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0012","unstructured":"CCC. Notice | Massachusetts Cannabis Control Commission Public Health and Safety Advisory: Potentially Contaminated Marijuana Products (sold between September 18, 2024, and January 30, 2025) | February 3, 2025. Cannabis Control Commission Massachusetts (CCC). https:\/\/masscannabiscontrol.com\/2025\/02\/notice-massachusetts-cannabis-control-commission-public-health-and-safety-advisory-potentially-contaminated-marijuana-products-sold-between-september-18-2024-and-january-30-2025-february-3\/(accessed 2026-03-07)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0013","unstructured":"CCC. Notice | Massachusetts Cannabis Control Commission Public Health and Safety Advisory: potentially Contaminated Marijuana Products (sold between May 31, 2024, and January 23, 2025) | February 4, 2025. Cannabis Control Commission Massachusetts (CCC). https:\/\/masscannabiscontrol.com\/2025\/02\/notice-massachusetts-cannabis-control-commission-public-health-and-safety-advisory-potentially-contaminated-marijuana-products-sold-between-may-31-2024-and-january-23-2025-february-3-2025\/(accessed 2026-03-07)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinthera.2025.12.011","article-title":"Safeguarding cannabis for medical use: clinical risks, regulatory gaps, and the path toward equitable standards","author":"Collins","year":"2026","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0015","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1108\/AAAJ-08-2020-4732","article-title":"Toward an omniopticon: the potential of blockchain technology toward influencing vulnerable populations in contested markets","volume":"35","author":"Carrasco","year":"2021","journal-title":"Account Audit Amp Account J"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0016","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.12688\/f1000research.9662.1","article-title":"Metagenomic analysis of medicinal cannabis samples; pathogenic bacteria, toxigenic fungi, and beneficial microbes grow in culture-based yeast and mold tests","volume":"5","author":"McKernan","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0017","series-title":"Recent Advances in the Science of Cannabis","first-page":"132","article-title":"Cannabis microbial testing: methodologies and considerations","author":"Boyar","year":"2021"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0018","unstructured":"The cannabis industry and work-related asthma and allergies | Blogs | CDC. https:\/\/blogs.cdc.gov\/niosh-science-blog\/2023\/11\/17\/cannabis-allergies\/(accessed 2025-08-11)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1520\/JTE20230619","article-title":"Agricultural agents: utilizing matrix calibrations for the accurate quantification of contaminants in cannabis products","volume":"53","author":"Glaros","year":"2025","journal-title":"J Test Eval"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0020","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.clinthera.2023.03.010","article-title":"A research agenda to inform cannabis regulation: how science can shape policy","volume":"45","author":"Schauer","year":"2023","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0021","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.accinf.2011.02.004","article-title":"A design science research methodology and its application to accounting information systems research","volume":"12","author":"Geerts","year":"2011","journal-title":"Int J Account Inf Syst"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0022","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.clinthera.2023.04.011","article-title":"History of cannabis regulation and medicinal therapeutics: it\u2019s complicated","volume":"45","author":"Johnson","year":"2023","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0023","series-title":"Regulated Cannabis and Hemp Market Navigation: Business, Public Health, and Research Challenges","first-page":"1","article-title":"Innovating in cannabis policy","author":"Slade","year":"2024"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0024","series-title":"American Chemical Society Spring Conference: Insights From FOIA Data on Cannabis Testing Across the U.S.","article-title":"Regional (in)consistency and comparability of cannabis laboratory testing","author":"Carrasco","year":"2025"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0025","unstructured":"Rules for the certification of cannabis testing facilities. 18-691 C.M.R. Ch. 5, 2024. https:\/\/www.maine.gov\/future\/sites\/maine.gov.dafs.omp\/files\/inline-files\/Administrative_Rule_18-691_CMR_ch5-Rules_Certification_Marijuana_Testing_Facilities.pdf (accessed 2025-08-10)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0026","unstructured":"Protocol for the sampling and analysis of finished marijuana products and marijuana products for marijuana establishments, medical marijuana treatment centers, and colocated marijuana operations, 2021. https:\/\/masscannabiscontrol.com\/wp-content\/uploads\/2021\/06\/Finished-Marijuana-Products-Sampling-and-Analysis-Protocol.pdf (accessed 2025-08-10)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0027","unstructured":"Microbiological examination of nonsterile products: tests for specified microorganisms. In: United States Pharmacopeia 34 Sixth Interim Revision Announcement. https:\/\/www.usp.org\/sites\/default\/files\/usp\/document\/harmonization\/gen-method\/q05a_pf_ira_34_6_2008.pdf (accessed 2025-08-10)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0028","unstructured":"Recommended Microbial Limits for Botanical Ingredients \u00a9 AHPA 2022, 2022. https:\/\/www.ahpa.org\/Files\/Document%20Library\/AHPAGuidancePolicies\/AHPA_micro_limits_comparisons.pdf (accessed 2025-08-10)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0029","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/(SICI)1520-6688(199921)18:2<226::AID-PAM2>3.0.CO;2-J","article-title":"The paradox of policy analysis: if it is not used, why do we produce so much of it?","volume":"18","author":"Shulock","year":"1999","journal-title":"J Policy Anal Manage"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1468-0491.2010.01481.x","article-title":"The usage of scientific knowledge by independent regulatory agencies","volume":"23","author":"Schrefler","year":"2010","journal-title":"Governance"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0031","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012738","article-title":"Interpretation and use of evidence in state policymaking: a qualitative analysis","volume":"7","author":"Apollonio","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2019.08.004","article-title":"Price and product variation in Washington\u2019s recreational cannabis market","volume":"91","author":"Davenport","year":"2021","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0033","unstructured":"Crabtree A, Carrasco H, Slade M, et al. Michigan cannabis market, taxation, and regulatory noncompliance analysis; Requirement of Public Act 166 of 2022; Grant Pilot Program P.A. 166 of 2022, sec. 1002; Michigan Cannabis Regulatory Agency (CRA): State of Michigan, 2024. https:\/\/www.michigan.gov\/lara\/-\/media\/Project\/Websites\/lara\/about\/Legislative-Reports\/Boilerplate-Required-Reports\/FY2023\/Section-1002-Cannabis-Market-Taxation-and-Regulatory-Compliance-Analysis-Pilot-Program.pdf?rev=551bf4057805438eb771438e4b60c628 (accessed 2025-08-04)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0034","article-title":"High time for change: how federal cannabis prohibition dooms the legal cannabis industry","volume":"19","author":"Kruger","year":"2023","journal-title":"J Bus Technol Law"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0035","unstructured":"The Maryland Cannabis Administration\u2019s Technical Authority for Cannabis Testing, 2025. https:\/\/cannabis.maryland.gov\/Documents\/2025%20Industry%20Licensees\/MCA%20Technical%20Authority%20Rev%206%20eff%20February%202025.pdf (accessed 2025-07-23)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0036","unstructured":"Warren B, Wernau J. Exclusive | Legal marijuana contains dangerous mold. States approve it anyway. WSJ. https:\/\/www.wsj.com\/health\/healthcare\/marijuana-mold-contaminants-safety-a172c230 (accessed 2025-08-12)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0037","unstructured":"Peacos P. Microbiological data integrity: points to consider regarding second analyst verification. American Pharmaceutical Review. https:\/\/www.americanpharmaceuticalreview.com\/Featured-Articles\/562304-Microbiological-Data-Integrity-Points-to-Consider-Regarding-Second-Analyst-Verification\/ (accessed 2026-03-07)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0038","unstructured":"2025 marijuana industry statistics. Flowhub. https:\/\/www.flowhub.com\/cannabis-industry-statistics (accessed 2025-08-12)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0039","unstructured":"LARA updates marijuana guidelines for active ingredients, safety tests, and remediation protocols. https:\/\/www.michigan.gov\/cra\/spotlight\/lara-updates-marijuana-guidelines-for-active-ingredients-safety-tests-and-remediation-protocols (accessed 2026-03-07)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/02791072.2017.1422816","article-title":"Regulating cannabis manufacturing: applying public health best practices from tobacco control","volume":"50","author":"Orenstein","year":"2018","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0041","unstructured":"Schaneman B. New York eases marijuana testing requirements for some contaminants. MJBizDaily. https:\/\/mjbizdaily.com\/news\/new-york-eases-marijuana-testing-requirements-for-some-contaminants\/344091\/ (accessed 2026-03-07)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0042","unstructured":"Florida administrative code | 5 \u2013 Department of Agriculture and Consumer Services | 5K \u2013 Division of Food Safety | Chapter 5K-4 \u2013 FOOD | Section 5K-4.034 \u2013 Hemp Extract for Human Consumption. Justia Law. https:\/\/regulations.justia.com\/states\/florida\/5\/5k\/chapter-5k-4\/section-5k-4-034\/(accessed 2025-08-12)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0043","unstructured":"Sampling and Testing-Technical Guidance for Marijuana Products, 2024. https:\/\/www.michigan.gov\/cra\/-\/media\/Project\/Websites\/cra\/bulletin\/5Technical\/Sampling_and_Testing-_Technical_Guidance_for_Marijuana_Products_694124_7.pdf (accessed 2025-07-24)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0044","unstructured":"RI validated methods. https:\/\/members.aoac.org\/AOAC\/AOAC\/RI\/PTM_Validated_Methods.aspx (accessed 2025-08-21)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4315\/0362-028X.JFP-15-357","article-title":"Comparison of new and traditional culture-dependent media for enumerating foodborne yeasts and molds","volume":"79","author":"Beuchat","year":"2016","journal-title":"J Food Prot"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0046","unstructured":"General Chapter <61> Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests, 2025. https:\/\/www.usp.org\/harmonization-standards\/pdg\/general-methods\/microbial-enumeration; https:\/\/www.usp.org\/sites\/default\/files\/usp\/document\/harmonization\/gen-method\/20240426HSm98800.pdf (accessed 2026-02-27)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0047","unstructured":"General Chapter <62> Microbiological Examination of Nonsterile Products: Tests for Specified Microorganisms, 2016. https:\/\/www.usp.org\/harmonization-standards\/pdg\/general-methods\/tests-specified-microorganism; https:\/\/www.usp.org\/sites\/default\/files\/usp\/document\/harmonization\/gen-method\/q05a_pf_ira_34_6_2008.pdf (accessed 2026-02-27)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0048","series-title":"Handbook of Water and Wastewater Microbiology","first-page":"113","article-title":"8 \u2013 Detection, enumeration and identification of environmental microorganisms of public health significance","author":"Kator","year":"2003"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0049","unstructured":"Falardeau J, McGloin E, Martiniuk J. No silver bullet: technical barriers to using qPCR for the enumeration of microbial contaminants in cannabis [White Paper], 2021. https:\/\/help.medicinalgenomics.com\/hubfs\/White%20Papers\/Technical%20barriers%20to%20using%20qPCR%20for%20the%20enumeration%20of%20microbial%20contaminants%20in%20Cannabis.pdf (accessed 2025-08-25)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0050","unstructured":"Cannlytics \u2013 open collective. https:\/\/opencollective.com\/cannlytics-company (accessed 2025-08-12)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0051","unstructured":"Data catalog. Cannabis Control Commission Massachusetts. https:\/\/masscannabiscontrol.com\/open-data\/data-catalog\/(accessed 2025-08-12)."},{"key":"10.1016\/j.clinthera.2026.03.019_bib0052","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.4315\/0362-028X-61.11.1535","article-title":"Estimating distributions of numbers of organisms in food products","volume":"61","author":"Marks","year":"1998","journal-title":"J Food Prot"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0053","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ijfoodmicro.2005.11.024","article-title":"Estimation of microbial growth using population measurements subject to a detection limit","volume":"108","author":"Shorten","year":"2006","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0054","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijfoodmicro.2012.01.023","article-title":"Fitting a lognormal distribution to enumeration and absence\/presence data","volume":"155","author":"Commeau","year":"2012","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0055","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.foodcont.2011.01.028","article-title":"Characterisation of within-batch and between-batch variability in microbial counts in foods using Poisson-gamma and Poisson-lognormal regression models","volume":"22","author":"Gonzales-Barron","year":"2011","journal-title":"Food Control"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0056","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijfoodmicro.2009.10.016","article-title":"Count data distributions and their zero-modified equivalents as a framework for modelling microbial data with a relatively high occurrence of zero counts","volume":"136","author":"Gonzales-Barron","year":"2010","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0057","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijfoodmicro.2010.01.025","article-title":"Estimating distributions out of qualitative and (semi)quantitative microbiological contamination data for use in risk assessment","volume":"138","author":"Busschaert","year":"2010","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.clinthera.2026.03.019_bib0058","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.3389\/fmicb.2018.02304","article-title":"Learning something from nothing: the critical importance of rethinking microbial non-detects","volume":"9","author":"Chik","year":"2018","journal-title":"Front Microbiol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826000810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826000810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:34:04Z","timestamp":1787070844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291826000810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0149291826000810"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.03.019","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regional (in)Consistency and Comparability of Cannabis Laboratory Testing: A Statistical Exploration of Total Yeast and Mold","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}